ArticleBiochemical genetics2026
Identification and Computational Analysis of a Novel Pathogenic DKC1 Variant Underlying X-Linked Dyskeratosis Congenita.
Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hematological complications in solid organ transplant recipients with telomere biology disorders: a narrative review.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Dyskeratosis congenita (DC) is an inherited progressive bone marrow failure disorder caused by defective telomeres maintenance. It is characterized by a triad of mucocutaneous abnormalities (reticulated skin pigmentation, nail dystrophy, oral leukoplakia) and an increased predisposition to cancer. Genetic mutations in fourteen genes causing abnormalities in telomere biology underlying the DC phenotype have been reported. This study aimed molecular investigation of DC segregating in a Pakistani family. We ascertained a four-generation family affected by the DC phenotype. Exome and Sanger sequencing and in silico tools were used to identify and validate pathogenic variant in the affected family. All affected individuals of the family presented with the classical triad of abnormalities and adermatoglyphia. Four out of five patients died from bone marrow failure before forty years of their age. We identified a novel DKC1 missense variant [NC_000023.11:g.154774671C > T, NP_001354.1:p.(Pro409Ser)] co-segregating with the disorder in an X-linked recessive pattern. In silico analyses supported the pathogenicity of the identified variant. Our study expands the DKC1 mutation pool, which would help further comprehend the molecular mechanisms underlying DC. There is a need to emphasize molecular genetic testing in clinical settings in Pakistan to provide early, noninvasive and accurate diagnosis of inherited diseases.
Indexed as
Identifiers
40634789What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.